ROBERT HAMILTON: Open Payments
NPI 1164431904 · NORMAL, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,142 in 23 payments from 5 companies in 2025. Trend: 2023 $8,546 · 2024 $15,765 · 2025 $17,142
Honoraria: $15,175Food & beverage: $1,100Travel & lodging: $866
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 17 | $16,666 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $237 |
| Neurocrine BioSciences, Inc. | 1 | $112 |
| E.R. Squibb & Sons, L.L.C. | 2 | $110 |
| Novo Nordisk Inc | 1 | $16 |
Products named: Auvelity, CAPLYTA, INGREZZA, COBENFY, Wegovy.
Industry payments across IL — which companies pay providers there.
